Body and Mind Inc. (BAMM.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 18.38 Million USD | 57.51% |
| 2022 | 11.67 Million USD | 2116.8% |
| 2021 | 526.49 Thousand USD | -58.97% |
| 2020 | 1.28 Million USD | 114.25% |
| 2019 | -9 Million USD | -586.7% |
| 2018 | 1.85 Million USD | 604.7% |
| 2017 | -366.58 Thousand USD | -582.04% |
| 2016 | 76.04 Thousand USD | 10.07% |
| 2015 | 69.09 Thousand USD | -11.23% |
| 2014 | 77.83 Thousand USD | -12.73% |
| 2013 | 89.18 Thousand USD | 81.65% |
| 2012 | 49.09 Thousand USD | 145.34% |
| 2011 | 20.01 Thousand USD | -60.04% |
| 2010 | 50.08 Thousand USD | 447.26% |
| 2009 | 9152.00 USD | 57300.0% |
| 2008 | -16.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 11.96 Million USD | 9.12% |
| 2024 Q2 | 10.96 Million USD | -14.86% |
| 2024 Q1 | 12.88 Million USD | -29.92% |
| 2023 Q1 | 12.23 Million USD | 4.87% |
| 2023 Q3 | 17.47 Million USD | 11.6% |
| 2023 Q4 | 18.38 Million USD | 5.2% |
| 2023 Q2 | 15.65 Million USD | 27.93% |
| 2023 FY | 18.38 Million USD | 57.51% |
| 2022 Q3 | 9.73 Million USD | 16.94% |
| 2022 Q2 | 8.32 Million USD | 1110.85% |
| 2022 Q1 | 687.64 Thousand USD | 30.61% |
| 2022 Q4 | 11.67 Million USD | 19.87% |
| 2022 FY | 11.67 Million USD | 2116.8% |
| 2021 Q2 | 1.4 Million USD | 8.31% |
| 2021 FY | 526.49 Thousand USD | -58.97% |
| 2021 Q1 | 1.29 Million USD | 0.81% |
| 2021 Q3 | 1.35 Million USD | -3.28% |
| 2021 Q4 | 526.49 Thousand USD | -61.15% |
| 2020 Q1 | -5.75 Million USD | 36.1% |
| 2020 FY | 1.28 Million USD | 114.25% |
| 2020 Q4 | 1.28 Million USD | 51.63% |
| 2020 Q3 | 846.31 Thousand USD | 137.24% |
| 2020 Q2 | -2.27 Million USD | 60.51% |
| 2019 Q2 | 2.78 Million USD | 34.25% |
| 2019 FY | -9 Million USD | -586.7% |
| 2019 Q4 | -9 Million USD | -381.7% |
| 2019 Q1 | 2.07 Million USD | 12.13% |
| 2019 Q3 | 3.19 Million USD | 14.77% |
| 2018 Q4 | 1.85 Million USD | 105.53% |
| 2018 Q2 | 496.41 Thousand USD | 110.6% |
| 2018 FY | 1.85 Million USD | 604.7% |
| 2018 Q1 | -4.68 Million USD | -1176.97% |
| 2018 Q3 | 900.21 Thousand USD | 81.34% |
| 2017 Q3 | -691.52 Thousand USD | -846.95% |
| 2017 Q2 | 92.57 Thousand USD | 25.65% |
| 2017 Q1 | 73.67 Thousand USD | -3.12% |
| 2017 FY | -366.58 Thousand USD | -582.04% |
| 2017 Q4 | -366.58 Thousand USD | 46.99% |
| 2016 Q1 | 69.79 Thousand USD | 1.01% |
| 2016 FY | 76.04 Thousand USD | 10.07% |
| 2016 Q4 | 76.04 Thousand USD | -2.83% |
| 2016 Q3 | 78.26 Thousand USD | 19.88% |
| 2016 Q2 | 65.28 Thousand USD | -6.46% |
| 2015 FY | 69.09 Thousand USD | -11.23% |
| 2015 Q4 | 69.09 Thousand USD | -5.86% |
| 2015 Q3 | 73.39 Thousand USD | 5.79% |
| 2015 Q2 | 69.37 Thousand USD | -8.06% |
| 2015 Q1 | 75.45 Thousand USD | -3.06% |
| 2014 Q1 | 79.51 Thousand USD | -10.85% |
| 2014 FY | 77.83 Thousand USD | -12.73% |
| 2014 Q3 | 76.78 Thousand USD | 3.16% |
| 2014 Q4 | 77.83 Thousand USD | 1.37% |
| 2014 Q2 | 74.43 Thousand USD | -6.39% |
| 2013 Q2 | 86.79 Thousand USD | 17.26% |
| 2013 Q4 | 89.18 Thousand USD | 0.99% |
| 2013 Q1 | 74.01 Thousand USD | 50.74% |
| 2013 FY | 89.18 Thousand USD | 81.65% |
| 2013 Q3 | 88.31 Thousand USD | 1.76% |
| 2012 Q2 | 39.6 Thousand USD | 1217.75% |
| 2012 Q1 | -3543.00 USD | -117.7% |
| 2012 Q3 | 49.87 Thousand USD | 25.95% |
| 2012 Q4 | 49.09 Thousand USD | -1.56% |
| 2012 FY | 49.09 Thousand USD | 145.34% |
| 2011 Q3 | -43.12 Thousand USD | -179.88% |
| 2011 Q4 | 20.01 Thousand USD | 146.4% |
| 2011 Q2 | 53.98 Thousand USD | 5.44% |
| 2011 Q1 | 51.2 Thousand USD | 2.23% |
| 2011 FY | 20.01 Thousand USD | -60.04% |
| 2010 Q2 | 13.27 Thousand USD | 7.82% |
| 2010 FY | 50.08 Thousand USD | 447.26% |
| 2010 Q1 | 12.31 Thousand USD | 34.52% |
| 2010 Q4 | 50.08 Thousand USD | 2.27% |
| 2010 Q3 | 48.97 Thousand USD | 268.94% |
| 2009 FY | 9152.00 USD | 57300.0% |
| 2009 Q2 | -351.00 USD | 6.9% |
| 2009 Q1 | -377.00 USD | 0.0% |
| 2009 Q3 | -472.00 USD | -34.47% |
| 2009 Q4 | 9152.00 USD | 2038.98% |
| 2008 FY | -16.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | -2125.277% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | -26170.414% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 2382.695% |
| The BC Bud Corporation | 225.15 Thousand CAD | -8065.014% |
| BioNxt Solutions Inc. | 4.53 Million CAD | -305.778% |
| CordovaCann Corp. | 6.13 Million CAD | -199.85% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | -297.22% |
| Captor Capital Corp. | -5.41 Million CAD | 439.776% |
| City View Green Holdings Inc. | 1.49 Million CAD | -1127.036% |
| 1CM Inc. | 3.31 Million CAD | -454.559% |
| Global Hemp Group Inc. | 3.55 Million CAD | -417.543% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | -26.876% |
| IM Cannabis Corp. | 11.96 Million CAD | -53.595% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | -9457.459% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | -643.114% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 410.799% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 4192.987% |
| Ovation Science Inc. | 143.76 Thousand CAD | -12687.288% |
| Pharmadrug Inc. | 1.2 Million CAD | -1423.485% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | -9769.952% |
| RAMM Pharma Corp. | -4.71 Million CAD | 490.174% |
| RIV Capital Inc. | -101.38 Million CAD | 118.133% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | 2404.164% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 92.926% |
| SLANG Worldwide Inc. | 20.83 Million CAD | 11.749% |
| 1933 Industries Inc. | 16.47 Million CAD | -11.562% |
| Red Light Holland Corp. | -13.56 Million CAD | 235.561% |
| Top Strike Resources Corp. | 13.24 Million CAD | -38.763% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | 18049.748% |
| Adastra Holdings Ltd. | 2.2 Million CAD | -733.988% |